p16 and human papillomavirus discordance in abdominal metastatic recurrence following chemoradiotherapy for gastric-type endocervical adenocarcinoma

Read full text Summarise with VIRAT
Authors: Roxanne Endozo Garcia, Marie Christine Valerie R. Mendoza
Cited by: 0
References: 22

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cervical carcinoma commonly spreads to adjacent structures and pelvic lymph nodes, with ovarian metastases being rare (0.6%–8%). Persistent high-risk human papillomavirus (HPV) infection, present in 95% of cervical cancers, is the primary etiologic factor, and p16 serves as a surrogate marker, although discordance may occur. We present a 53-year-old woman with prior endocervical adenocarcinoma who developed metastatic recurrence to the ovary, fallopian tube, omentum, and appendix, 8 months after concurrent chemoradiation and brachytherapy. The ovarian specimen and the previous cervical biopsy tissue tested positive for p16, with the ovarian specimen consistent with metastatic adenocarcinoma from the cervix. However, the subjection of both specimens to HPV testing yielded negative results. Studies have shown intermediate survival outcomes for p16+/HPV − cancers and shorter survival outcomes for p16−/HPV − and HPV+/p16 − cancers. Although HPV status currently does not alter cervical cancer management, understanding the prognostic and potential therapeutic implications of p16 and HPV discordance remains an important area for future research.

Fields of Study & Subjects

Cervical Cancer and HPV Research Endometrial and Cervical Cancer Treatments Metastasis and carcinoma case studies

Publication details

Journal / source
Philippine Journal of Obstetrics and Gynecology
Volume
50
Issue
1
Pages
60–65
Publication date
1 January 2026
Language
EN